Please Wait...

BioClinica and SYNARC - One Mission. One Company.

BioClinica and SYNARC have merged to create the world's foremost medical imaging and cardiovascular core lab with unrivalled scientific and operational capabilities for advancing clinical trials. Together, our company now offers the industry's most comprehensive clinical imaging program to support all pharmaceutical, biotechnology, and device companies in their efforts to develop next generation treatments across major therapeutic areas.

The new BioClinica will combine the talent and the best practices of both companies, providing a broader and more diversified suite of clinical trial services, greater scientific expertise and increased operational scale to our clients. Our combination of world class scientific expertise, deep clinical trial experience and innovative technologies are proven to reduce clinical trial costs, shorten drug development time, and improve data quality and regulatory compliance.

 

 

Support for Your Trial
SynarcConnect Portal
For concerns, contact us at websupport@synarc.com

 

 

BioClinica Imaging Global Centers

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

"Mud run" 1 obstacle in vaccine trials w elderly. Here R 5 more & how to conquer by Dr. Craig Curtis… https://t.co/vIk4B2Howd
bioclinica (2 hours ago)
What's new in tech for ICH E6 R2 reqs for quality and #RBM? https://t.co/xsmNm8d35o #Pharma
bioclinica (5 hours ago)
Vaccine clinical trials: Boost senior participation following simple advice from Dr. Craig Curtis… https://t.co/OuTKyu0DPT
bioclinica (6 hours ago)
RT @ElisendaGendra: Decision on #EMA Relocation Set for November, Council Agrees on Bidding Procedure via @RAPSorg https://t.co/a42Eszg81o…
bioclinica (Yesterday)
@Xtalks Looking forward to tomorrow's webinar on site payments!
bioclinica (Yesterday)
Conducting Lymphoma ClinicalTrials? Lugano 2014 criteria for assessing FDG-PET/CT. An operational appch https://t.co/x5bdpI8jUI
bioclinica (Yesterday)

Latest Blogs: